Literature DB >> 2250287

Hepatotoxic activity of Campylobacter jejuni.

E Kita1, D Oku, A Hamuro, F Nishikawa, M Emoto, Y Yagyu, N Katsui, S Kashiba.   

Abstract

Hepatotoxic factor(s) were isolated from whole-cell lysates of Campylobacter jejuni GIFU 8734 and purified by chromatography. A single intravenous injection of 10 micrograms of this factor reproducibly produced hepatitis in mice, as determined by histology and liver function tests. The hepatic lesions were very similar to those evoked by C. jejuni infection. Tissue-culture studies with mouse hepatocytes demonstrated that low concentrations of the factor caused release of hepatic enzymes into the medium without appreciable cytolysis. High concentrations of the factor induced cytolysis. These effects were neutralised by antiserum to the factor, but not by antisera to the lipopolysaccharide of C. jejuni or to the heat-labile enterotoxin of Escherichia coli. Among 20 clinical isolates of C. jejuni, only four evoked hepatitis in mice and produced the hepatotoxic factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250287     DOI: 10.1099/00222615-33-3-171

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.

Authors:  J M Rice
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

Review 3.  Acute hepatitis associated with Campylobacter jejuni bacteraemia.

Authors:  T M Korman; C C Varley; D W Spelman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

4.  Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus.

Authors:  J G Fox; L Yan; B Shames; J Campbell; J C Murphy; X Li
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis.

Authors:  L S Mansfield; J A Bell; D L Wilson; A J Murphy; H M Elsheikha; V A K Rathinam; B R Fierro; J E Linz; V B Young
Journal:  Infect Immun       Date:  2006-11-27       Impact factor: 3.441

6.  First attempt to produce experimental Campylobacter concisus infection in mice.

Authors:  Rune Aabenhus; Unne Stenram; Leif Percival Andersen; Henrik Permin; Asa Ljungh
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

7.  Newborn piglet model for campylobacteriosis.

Authors:  F K Babakhani; G A Bradley; L A Joens
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  Chronic active hepatitis in mice caused by Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; R E Benveniste
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains.

Authors:  James G Fox; Arlin B Rogers; Mark T Whary; Zhongming Ge; Nancy S Taylor; Sandy Xu; Bruce H Horwitz; Susan E Erdman
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.